ShardaCare Healthcity, a leading super-speciality hospital in Greater Noida, renowned for its advanced clinical capabilities and patient-centric approach, is organising a bone marrow transplant (BMT) ...
Over 300 patients and families screened; initiative led by Dr. Sunil Bhat aims to accelerate access to curative bone marrow transplants. Kolkata, December 22, 2025: Narayana Health City, Bengaluru, ...
There is no specific “diagnostic” or pathognomonic laboratory marker for ankylosing spondylitis/axial spondyloarthritis (AS/axSpA), and diagnosis is based on clinical history, physical examination and ...
Among the 6.8% of study patients with inflammatory bowel disease who developed new musculoskeletal symptoms, 30 were ultimately diagnosed with spondyloarthritis. Approximately 7% of patients with ...
Greater use of immunosuppressive therapies, particularly at younger ages, appears to coincide with a reduction in juvenile idiopathic arthritis-associated uveitis in the United States. Both the ...
Clinical experts reviewed the relationships between uveitis findings and potential systemic disease. Uveitis type can be determined based on either the location of the inflammation within the uvea, or ...
Testing for the HLA-B27 allele showed widespread use across specialties and revealed missed opportunities for rheumatology referrals in positive cases. They analyzed records of all adults tested for ...
A phase I study of AFNT-211, autologous CD4+ and CD8+ T cells engineered to express a high avidity HLA-A*11:01-restricted, KRAS G12V-specific transgenic TCR; CD8α/β coreceptor; and FAS-41BB switch ...
1 Key Laboratory of Bioresources and Eco-Environment of MOE, College of Life Sciences, Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, Department of Pediatrics, West ...
Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. Across the world of ...
Human leukocyte antigen B27 (HLA-B27) positivity was associated with higher odds of non-remission in patients with juvenile idiopathic arthritis (JIA) at 18 years after disease onset, with men showing ...